ATE442592T1 - Detektion und/oder beobachtung von synuclein- assoziierten krankheiten - Google Patents
Detektion und/oder beobachtung von synuclein- assoziierten krankheitenInfo
- Publication number
- ATE442592T1 ATE442592T1 AT03709934T AT03709934T ATE442592T1 AT E442592 T1 ATE442592 T1 AT E442592T1 AT 03709934 T AT03709934 T AT 03709934T AT 03709934 T AT03709934 T AT 03709934T AT E442592 T1 ATE442592 T1 AT E442592T1
- Authority
- AT
- Austria
- Prior art keywords
- synuclein
- monitoring
- detection
- patient
- associated diseases
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0203446.0A GB0203446D0 (en) | 2002-02-14 | 2002-02-14 | Detection and/or monitoring of synuclein-related diseases |
PCT/GB2003/000677 WO2003069332A2 (en) | 2002-02-14 | 2003-02-14 | Detection and/or monitoring of synuclein-related diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE442592T1 true ATE442592T1 (de) | 2009-09-15 |
Family
ID=9931023
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03709934T ATE442592T1 (de) | 2002-02-14 | 2003-02-14 | Detektion und/oder beobachtung von synuclein- assoziierten krankheiten |
Country Status (9)
Country | Link |
---|---|
US (1) | US20050176078A1 (de) |
EP (1) | EP1476758B2 (de) |
JP (1) | JP2005528588A (de) |
AT (1) | ATE442592T1 (de) |
AU (1) | AU2003214364A1 (de) |
CA (1) | CA2480466C (de) |
DE (1) | DE60329165D1 (de) |
GB (1) | GB0203446D0 (de) |
WO (1) | WO2003069332A2 (de) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040146521A1 (en) * | 1999-06-01 | 2004-07-29 | Schenk Dale B. | Prevention and treatment of synucleinopathic disease |
US8506959B2 (en) * | 2002-11-01 | 2013-08-13 | Neotope Biosciences Limited | Prevention and treatment of synucleinopathic and amyloidogenic disease |
US20080014194A1 (en) * | 2003-10-31 | 2008-01-17 | Elan Pharmaceuticals, Inc. | Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease |
US8697082B2 (en) * | 2002-11-01 | 2014-04-15 | Neotope Biosciences Limited | Prevention and treatment of synucleinopathic and amyloidogenic disease |
US9034337B2 (en) | 2003-10-31 | 2015-05-19 | Prothena Biosciences Limited | Treatment and delay of outset of synucleinopathic and amyloidogenic disease |
TW200509968A (en) * | 2002-11-01 | 2005-03-16 | Elan Pharm Inc | Prevention and treatment of synucleinopathic disease |
US7358331B2 (en) * | 2003-05-19 | 2008-04-15 | Elan Pharmaceuticals, Inc. | Truncated fragments of alpha-synuclein in Lewy body disease |
WO2005047860A2 (en) | 2003-11-08 | 2005-05-26 | Elan Pharmaceuticals, Inc. | Antibodies to alpha-synuclein |
DE10361258A1 (de) | 2003-12-24 | 2005-07-28 | Schwarz Pharma Ag | Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson |
DE102004014841B4 (de) | 2004-03-24 | 2006-07-06 | Schwarz Pharma Ag | Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms |
ES2310057B1 (es) * | 2004-07-19 | 2009-11-17 | Oryzon Genomics, S.A. | Metodo de analisis molecular y tratamiento en demencia de cuerpos de lewy. |
CN1752104B (zh) * | 2004-09-21 | 2010-05-05 | 北京市肿瘤防治研究所 | 突触蛋白γ的单克隆抗体及其应用 |
CA2657953A1 (en) * | 2005-07-19 | 2007-01-25 | University Of Rochester | Alpha-synuclein antibodies and methods related thereto |
IL199534A (en) | 2007-01-05 | 2013-01-31 | Univ Zuerich | An isolated human antibody capable of detecting a neoepitope in a disease-related protein, a polynucleotide encoding an antibody, a vector containing the polynucleotide, a host cell containing the polynucleotide or vector, a preparation containing the antibody and related methods and uses. |
US8147833B2 (en) * | 2007-02-23 | 2012-04-03 | Neotope Biosciences Limited | Prevention and treatment of synucleinopathic and amyloidogenic disease |
CA2678963C (en) * | 2007-02-23 | 2018-05-01 | Elan Pharmaceuticals, Inc. | Prevention and treatment of synucleinopathic and amyloidogenic disease |
GB0716885D0 (en) | 2007-08-30 | 2007-10-10 | United Arab Emirates Universit | Diagnostic agent |
ES2544569T3 (es) | 2008-12-19 | 2015-09-01 | Biogen International Neuroscience Gmbh | Autoanticuerpos humanos anti alfa-sinucleina |
WO2011033252A1 (en) * | 2009-09-16 | 2011-03-24 | United Arab Emirates University | Diagnostic agent for parkinson's disease |
CN101692092B (zh) * | 2009-09-24 | 2013-04-10 | 首都医科大学宣武医院 | 定量检测人血清中自体α-突触核蛋白抗体的方法 |
US10989718B2 (en) * | 2014-09-11 | 2021-04-27 | Amprion, Inc. | Detection of misfolded alpha synuclein protein |
US20130309690A1 (en) * | 2010-11-05 | 2013-11-21 | The Brigham And Women's Hospital, Inc. | Tetrameric alpha-synuclein as biomarkers |
JP6006908B2 (ja) * | 2010-11-05 | 2016-10-12 | ブランダイス ユニバーシティBrandeis University | Ice阻害化合物およびその使用 |
AU2011336895A1 (en) * | 2010-11-24 | 2013-06-06 | Elan Pharmaceuticals, Inc. | Phagocytic activity as a marker of synucleinopathic disease |
DK2723379T3 (en) * | 2011-06-23 | 2018-10-15 | Biogen Int Neuroscience Gmbh | ANTI-ALPHA SYNUCLEIN BINDING MOLECULES |
US20140295465A1 (en) * | 2011-11-02 | 2014-10-02 | Biogen Idec International Neuroscience Gmbh | USE OF AN ANTI-alpha-SYNUCLEIN ANTIBODY TO DIAGNOSE AN ELEVATED LEVEL OF alpha-SYNUCLEIN IN THE BRAIN |
ES2481517B1 (es) * | 2013-01-29 | 2015-06-01 | Universidad De Sevilla | Método para el diagnóstico de la enfermedad de parkinson en estadios tempranos |
ES2953855T3 (es) * | 2014-09-11 | 2023-11-16 | Univ Texas | Detección de proteínas mal plegadas |
EP3961216B1 (de) | 2014-11-14 | 2024-02-14 | United Arab Emirates University | Dihydromyricetin zur verwendung als bildgebungsmittel |
MA41115A (fr) | 2014-12-02 | 2017-10-10 | Biogen Int Neuroscience Gmbh | Procédé de traitement de la maladie d'alzheimer |
CN104711280B (zh) * | 2014-12-10 | 2018-04-13 | 中国医学科学院医学生物学研究所 | 表达和纯化同时缺失外显子3和5 的α突触核蛋白选择性剪切体蛋白的方法 |
CA3062876A1 (en) | 2017-05-16 | 2018-11-22 | Amprion, Inc. | Detection of misfolded tau protein |
CA3067135A1 (en) * | 2017-06-19 | 2018-12-27 | Kainos Medicine Inc. | Modulators of alpha-synuclein |
WO2019040612A1 (en) | 2017-08-22 | 2019-02-28 | Biogen Ma Inc. | PHARMACEUTICAL COMPOSITIONS CONTAINING ANTI-BETA-AMYLOID ANTIBODIES |
JP7173532B2 (ja) * | 2018-08-28 | 2022-11-16 | 学校法人順天堂 | α-シヌクレイノパチーの診断 |
RU2703430C1 (ru) * | 2018-12-13 | 2019-10-16 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр глазных болезней имени Гельмгольца" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ ГБ им. Гельмгольца" Минздрава России) | Способ прогнозирования развития нейродегенеративных заболеваний, в основе патогенеза которых лежит гамма-синуклеинопатия |
EP3779448A1 (de) * | 2019-08-12 | 2021-02-17 | Baden-Württemberg Stiftung gGmbH | Neuartiger diagnostischer marker für die creutzfeldt-jakob-krankheit und morbus-alzheimer |
EP4111197A1 (de) * | 2020-02-25 | 2023-01-04 | Markus Otto | Diagnose einer mit synaptischer degeneration assoziierten erkrankung mittels elisa zur bestimmung einer beta-synuklein-konzentration in csf |
US20240003918A1 (en) | 2020-11-30 | 2024-01-04 | Enigma Biointelligence, Inc. | Non-invasive assessment of alzheimer's disease |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5602042A (en) * | 1994-04-14 | 1997-02-11 | Cytyc Corporation | Method and apparatus for magnetically separating biological particles from a mixture |
WO1999050300A1 (en) * | 1998-03-30 | 1999-10-07 | The Trustees Of The University Of Pennsylvania | Method of identifying, diagnosing and treating synuclein positive neurodegenerative disorders |
BR9911291A (pt) * | 1998-07-03 | 2001-12-04 | Innogenetics Nv | Diagnóstico diferencial de neurodegeneração |
JP2004502781A (ja) * | 2000-07-07 | 2004-01-29 | パナシア ファーマシューティカルズ インコーポレーテッド | 神経組織の損傷を予防するため、およびα−シヌクレイン疾患を処置するための方法 |
US20020150948A1 (en) * | 2000-11-03 | 2002-10-17 | Gerardo Castillo | Antibody PTI-HS7 for treatment of alzheimer's disease and other amyloidoses and parkinson's disease |
-
2002
- 2002-02-14 GB GBGB0203446.0A patent/GB0203446D0/en not_active Ceased
-
2003
- 2003-02-14 WO PCT/GB2003/000677 patent/WO2003069332A2/en active Application Filing
- 2003-02-14 EP EP03709934.8A patent/EP1476758B2/de not_active Expired - Lifetime
- 2003-02-14 CA CA2480466A patent/CA2480466C/en not_active Expired - Fee Related
- 2003-02-14 AT AT03709934T patent/ATE442592T1/de not_active IP Right Cessation
- 2003-02-14 AU AU2003214364A patent/AU2003214364A1/en not_active Abandoned
- 2003-02-14 DE DE60329165T patent/DE60329165D1/de not_active Expired - Lifetime
- 2003-02-14 US US10/503,416 patent/US20050176078A1/en not_active Abandoned
- 2003-02-14 JP JP2003568402A patent/JP2005528588A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2003214364A1 (en) | 2003-09-04 |
EP1476758A2 (de) | 2004-11-17 |
CA2480466C (en) | 2010-12-21 |
US20050176078A1 (en) | 2005-08-11 |
JP2005528588A (ja) | 2005-09-22 |
EP1476758B2 (de) | 2015-02-11 |
WO2003069332A2 (en) | 2003-08-21 |
DE60329165D1 (de) | 2009-10-22 |
EP1476758B1 (de) | 2009-09-09 |
CA2480466A1 (en) | 2003-08-21 |
GB0203446D0 (en) | 2002-04-03 |
WO2003069332A3 (en) | 2004-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE442592T1 (de) | Detektion und/oder beobachtung von synuclein- assoziierten krankheiten | |
DE60331921D1 (de) | Diagnose und prävention der krebszellinvasion | |
DE60312309D1 (de) | Verwendung von botulinum toxin zur behandlung von herz- und kreislaufskrankheiten | |
DE60108230D1 (de) | Vorrichtung für diagnose und behandlung von arrhytmien | |
DE602004010407D1 (de) | Fluorsubstituierter omega-carboxyaryldiphenylharnstoff zur behandlung und prävention von krankheiten und leiden | |
ATE423217T1 (de) | Assays zur überwachung von krebspatienten auf grundlage der spiegel von analytenkomponenten des plasminogen-aktivator-systems in proben von körperflüssigkeiten | |
ATE411399T1 (de) | Behandlung der huntington's krankheit mit epa | |
CY1110503T1 (el) | Πενταμιδινη για θεραπεια καρκινου | |
WO2003087831A3 (en) | Proteins involved in breast cancer | |
MX2009005941A (es) | Ensayos de diagnostico complementario para terapia de cancer. | |
EP1501531A4 (de) | Verfahren zur behandlung von angst und stimmungsstörungen bei älternen personen | |
WO2006047475A3 (en) | Detection and analysis of ophthalmically-relevant fluorescent molecules | |
DE60122673D1 (de) | Methoden zur diagnose und behandlung von herzkrankheiten | |
ATE430935T1 (de) | Nachweis und behandlung von prostatakrebs | |
ATE552776T1 (de) | Verfahren und vorrichtung zur überwachung eines sedierten patienten | |
ATE520987T1 (de) | Verfahren zum nachweis und/oder screening zur überwachung eines kolorektalkrebs in einem individuum | |
DE60327530D1 (de) | Plasma urotensin und menschliche herzerkrankung | |
ATE452395T1 (de) | Verfahren und vorrichtung zum kommunizieren mit beistehenden im fall eines katastrophalen persönlichen notfalls | |
AU2003272189A8 (en) | Caspase inhibitors for the treatment of diseases and conditions caused by exposure to radionuclides, biological agents, or chemical agents | |
ATE393243T1 (de) | Diagnostisches verfahren der mastozytose | |
TW200613032A (en) | Uses for augmenting bone | |
ATE554790T1 (de) | Verfahren und zusammensetzungen zur diagnose von asthma | |
WO2004034994A3 (en) | Methods and compositions for determining risk of treatment toxicity | |
ATE397090T1 (de) | Verfahren und verbindungen zur diagnose von entzündlichen erkrankungen und identifizierung von pharmakologischen mitteln zur behandlung von entzündlichen erkrankungen | |
MXPA05006765A (es) | Procedimiento de deteccion de prp utilizando un antibiotico de aminoglicosidos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |